viewArcher Materials Ltd

Full interview: Archer Materials lodges graphene biosensor technology international patent application

Archer Materials Limited (ASX:AXE) chief executive officer Dr Mohammad Choucair updates Proactive on the filing of an international patent application to commercialise the company’s ground-breaking graphene biosensor technology and protect its international property.

Archer is a leader in developing technology for the use of graphene materials for human health, which could provide potential solutions, for example, to rapid, highly sensitive and portable testing for in-vitro diagnostics.

The company’s biosensor technology is unique in that it uses digital manufacturing to print critical ultrasensitive graphene material components that are integrated into one of a number of sensors.

Quick facts: Archer Materials Ltd

Price: 0.97 AUD

Market: ASX
Market Cap: $219.16 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Archer Materials Ltd named herein, including the promotion by the Company of Archer Materials Ltd in any Content on the Site, the Company...


Archer Materials CEO talks latest achievement of electronic transport in a...

Archer Materials Ltd's (ASX:AXE) (OTCMKTS:ARRXF) (FRA:38A) CEO Dr Mohammad Choucair speaks to Proactive's Andrew Scott following the news of a key technological milestone with electronic transport achieved in a single qubit at room temperature. This work forms part of Archer’s 12CQ quantum...

5 days, 6 hours ago

2 min read